Trialbee’s Smart Patient Matching drives 30% referral conversion rate
A large global pharma initiated a phase III study testing the efficacy of combining two existing drugs in overactive bladder patients.
Offered Free by: Trialbee AB
See All Resources from: Trialbee AB
Source: Cytiva Drug discovery is a complex, high-risk process, but new technologies are reshaping what’s…
California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…
Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…